FIELD: non-alcoholic steatohepatitis treatment.
SUBSTANCE: invention relates to 2-[(1R,3r,5S)-3-({5-cyclopropyl-3-[2-(trifluoromethoxy) phenyl]-1,2-oxazole-4-yl}methoxy)-8-azabicyclo[3.2.1]octane-8-yl]-4-fluorine-1,3-benzothiazole-6-carboxylic acid for non-alcoholic steatohepatitis treatment (NASH), where the specified compound should be injected at doses of 10 mcg, 30 mcg, 60 mcg, 90 mcg, 120 mcg.
EFFECT: non-alcoholic steatohepatitis treatment.
5 cl, 5 ex, 5 tbl, 5 dwg
| Title |
Year |
Author |
Number |
| METHODS OF USING AGONISTS FXR |
2017 |
- Laffitte, Bryan
- Badman, Michael
- Chen, Jin
- Lindgren, Sam
|
RU2737324C2 |
| DEUTERATED DERIVATIVE OF CHENODEOXYCHOLIC ACID AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUND |
2016 |
- Lv, Binhua
- Sheng, Zelin
- Li, Chengwei
|
RU2712033C2 |
| NOVEL PHARMACEUTICAL USE OF THIENO[3,2-D]PYRIMIDIN-4-ONE COMPOUNDS |
2019 |
- Liu, Hong
- Li, Jia
- Wang, Jiang
- Zang, Yi
- Li, Jian
- Li, Jingya
- Sun, Dandan
- Jiang, Hualiang
- Chen, Kaixian
|
RU2768828C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF NON-ALCOHOLIC STEATHOEPATITIS |
2021 |
- Kim, Mi-Kyung
- Park, Hansu
- Lee, Seung Ho
|
RU2803733C1 |
| COMPOSITION COMPRISING A GLP-1 RECEPTOR AGONIST AND A GLUCAGON RECEPTOR AGONIST, AND USE THEREOF |
2016 |
- Syuj Min
- Lv Vej
- Chzhan Inkhoj
- Lo Syaosu
|
RU2719144C2 |
| COMBINATIONS FOR TREATING NASH/NAFLD AND ASSOCIATED DISEASES |
2019 |
- Esler, William Paul
- Ross, Trenton Thomas
|
RU2776369C1 |
| METHOD OF TREATING HEPATIC FIBROSES |
2017 |
|
RU2740902C2 |
| NALMEFEN, NALTREXONE OR DERIVATIVES THEREOF FOR USE IN TREATING (NON)-ALCOHOLIC STEATOHEPATITIS OR NON-ALCOHOLIC FATTY LIVER DISEASE |
2017 |
- Wu, Edwin, Sc
- Chiu, Peter, J.S.
- Hsu, May, Mei-Chi
|
RU2717677C1 |
| COMBINED THERAPY WITH GPR119 AGONISTS AND DPP-4 INHIBITORS |
2020 |
- Patil, Rakesh Iswar
- Ali, Sazid
- Bapuram, Srinivasa Reddy
- Rai, Santosh Kumar
- Kumar, Anil
|
RU2818562C2 |
| NOVEL PROTEIN CONJUGATE AND USE THEREOF FOR PREVENTING OR TREATING NON-ALCOHOLIC STEATOHEPATITIS, OBESITY AND DIABETES |
2021 |
- Kim, Yunki
- Kim, Minsun
- Kim, Ryuryun
- Choi, Jaeyoung
- Yim, Yeseal
- Shim, Myungbo
- Han, Daye
- Im, Daeseong
- Park, Sungjin
|
RU2822001C1 |
